Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 488 | 220 | 70 | 443 | 295 |
| Receivables | 550 | 1,307 | 870 | 809 | 969 |
| TOTAL | $1,121 | $1,612 | $1,083 | $1,421 | $1,432 |
| Non-Current Assets | |||||
| PPE Net | 19 | 20 | 22 | 25 | 28 |
| TOTAL | $19 | $20 | $22 | $25 | $28 |
| Total Assets | $1,139 | $1,632 | $1,105 | $1,446 | $1,459 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,043 | 6,724 | 5,419 | 309 | 265 |
| Accounts payable and accrued liabilities | 3,082 | 3,306 | 3,101 | 2,753 | 2,698 |
| TOTAL | $10,156 | $10,061 | $8,555 | $3,090 | $2,987 |
| Non-Current Liabilities | |||||
| Long Term Debt | 597 | 621 | 649 | 5,576 | 5,700 |
| TOTAL | $597 | $621 | $649 | $5,576 | $5,700 |
| Total Liabilities | $10,753 | $10,682 | $9,203 | $8,666 | $8,686 |
| Shareholders' Equity | |||||
| Common Shares | 31,023 | 30,926 | 31,374 | 31,082 | 31,544 |
| Retained earnings | -52,352 | -51,644 | -51,219 | -49,932 | -50,559 |
| Other shareholders' equity | 2,078 | 2,071 | 2,205 | 2,185 | 2,402 |
| TOTAL | $-9,614 | $-9,051 | $-8,099 | $-7,220 | $-7,227 |
| Total Liabilities And Equity | $1,139 | $1,632 | $1,105 | $1,446 | $1,459 |